Foster Dykema Cabot & Partners, LLC Organon & Co. Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.52 Trillion
- Q3 2025
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Organon & Co. stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 2,711 shares of OGN stock, worth $20,413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,711Holding current value
$20,413% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OGN
# of Institutions
788Shares Held
197MCall Options Held
2.5MPut Options Held
2.94M-
Vanguard Group Inc Valley Forge, PA35.9MShares$271 Million0.01% of portfolio
-
Black Rock Inc. New York, NY32.6MShares$245 Million0.02% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.5MShares$71.6 Million0.03% of portfolio
-
State Street Corp Boston, MA9.34MShares$70.3 Million0.0% of portfolio
-
Lsv Asset Management Chicago, IL7.83MShares$59 Million0.18% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $1.92B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...